Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01279395 · ClinicalTrials.gov registry record
Anti-inflammatory Agents and Cholesterol Metabolism
A clinical trial, sponsored by Winthrop University Hospital.
- Terminated
- Registry status
- 3
- Enrollment target
NCT01279395: Clinical Trial study, sponsored by Winthrop University Hospital.
NCT01279395 is a clinical trial that was terminated before completion, run by Winthrop University Hospital. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01279395 was terminated before completion, sponsored by Winthrop University Hospital.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
We hypothesize that administration of anti-inflammatory medications such as celecoxib, naprosyn and diclofenac will cause changes in the blood plasma and white blood cells of patients such that they will be less able to efficiently process cholesterol.
Primary Outcome
PBMC are isolated directly from patient blood by Ficoll hypaque gradient centrifugation. Total RNA is obtained (TriZol) from PBMC. 27-hydroxylase message is quantitated by quantitative real-time polymerase chain reaction (QRT-PCR) using specific primers.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2010-11 |
| Est. Completion | 2018-01-18 |
Why NCT01279395 stopped before completion
NCT01279395 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01279395 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01279395 about?
NCT01279395 is a clinical study titled "Anti-inflammatory Agents and Cholesterol Metabolism". We hypothesize that administration of anti-inflammatory medications such as celecoxib, naprosyn and diclofenac will cause changes in the blood plasma and white blood cells of patients such that they will be less able to efficiently process cholesterol.
What is the current status of trial NCT01279395?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2010-11. Estimated completion is 2018-01-18.
Who is sponsoring clinical trial NCT01279395?
This trial is sponsored by Winthrop University Hospital, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia